← Eichor · All briefs

NCT04643067 — SLE trial site landscape

Public-registry site landscape for NCT04643067, a SLE study sponsored by Kangpu Biopharmaceuticals, Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.

TrialNCT04643067 (registry record)
SponsorKangpu Biopharmaceuticals, Ltd.
Condition(s)SLE; Drug
PhasePHASE1 / PHASE2
Listed sites18
Site countriesUnited States

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT04643067 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.